Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway

被引:70
作者
Jover-Mengual, Teresa [2 ]
Miyawaki, Takahiro [2 ]
Latuszek, Adrianna [2 ]
Alborch, Enrique [1 ]
Zukin, R. Suzanne [2 ]
Etgen, Anne M. [2 ]
机构
[1] Hosp Univ La Fe, Ctr Invest, Valencia, Spain
[2] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA
关键词
Estradiol; PI3K/Akt/signaling; Neuronal death; Apoptosis; Global ischemia; LONG-TERM POTENTIATION; FLUOROCHROME-LABELED INHIBITORS; DENDRITIC SPINE DENSITY; ESTROGEN-RECEPTOR-ALPHA; FOCAL CEREBRAL-ISCHEMIA; INJURY-INDUCED DECREASE; GROWTH-FACTOR-I; GLOBAL-ISCHEMIA; 17-BETA-ESTRADIOL PRETREATMENT; PHOSPHATIDYLINOSITOL; 3-KINASE;
D O I
10.1016/j.brainres.2010.01.046
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Global ischemia arising during cardiac arrest or cardiac surgery causes highly selective, delayed death of hippocampal CA1 neurons. Exogenous estradiol ameliorates global ischemia-induced neuronal death and cognitive impairment in male and female rodents. However, the molecular mechanisms by which a single acute injection of estradiol administered after the ischemic event intervenes in global ischemia-induced apoptotic cell death are unclear. Here we show that acute estradiol acts via the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling cascade to protect CA1 neurons in ovariectomized female rats. We demonstrate that global ischemia promotes early activation of glycogen synthase kinase-3 beta (GSK3 beta) and forkhead transcription factor of the O class (FOXO)3A, known Akt targets that are related to cell survival, and activation of caspase-3. Estradiol prevents ischemia-induced dephosphorylation and activation of GSK3 beta and FOXO3A, and the caspase death cascade. These findings support a model whereby estradiol acts by activation of PI3K/Akt signaling to promote neuronal survival in the face of global ischemia. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 80 条
[1]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[2]   From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens [J].
Amantea, D ;
Russo, R ;
Bagetta, G ;
Corasaniti, MT .
PHARMACOLOGICAL RESEARCH, 2005, 52 (02) :119-132
[3]   Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors [J].
Amstad, PA ;
Yu, G ;
Johnson, GL ;
Lee, BW ;
Dhawan, S ;
Phelps, DJ .
BIOTECHNIQUES, 2001, 31 (03) :608-+
[4]   Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA):: Correlation with DNA fragmentation [J].
Bedner, E ;
Smolewski, P ;
Amstad, P ;
Darzynkiewicz, Z .
EXPERIMENTAL CELL RESEARCH, 2000, 259 (01) :308-313
[5]   Oestrogen as a neuroprotective hormone [J].
Behl, C .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (06) :433-442
[6]   The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus [J].
Bi, RF ;
Broutman, G ;
Foy, MR ;
Thompson, RF ;
Baudry, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3602-3607
[7]   DMSO as a vehicle for central injections: tests with feeding elicited by norepinephrine injected into the paraventricular nucleus [J].
Blevins, JE ;
Stanley, BG ;
Reidelberger, RD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (1-2) :277-282
[8]   Programmed cell death mechanisms in neurological disease [J].
Bredesen, Dale E. .
CURRENT MOLECULAR MEDICINE, 2008, 8 (03) :173-186
[9]   Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway [J].
Brunet, A ;
Datta, SR ;
Greenberg, ME .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :297-305
[10]   Multiple pathways transmit neuroprotective effects of gonadal steroids [J].
Bryant, Damani N. ;
Sheldahl, Laird C. ;
Marriott, Lisa K. ;
Shapiro, Robert A. ;
Dorsa, Daniel M. .
ENDOCRINE, 2006, 29 (02) :199-207